Institutional & Family Asset Management, LLC Halozyme Therapeutics, Inc. Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$30.28 - $38.74 $484 - $619	-16 Reduced 51.61%	15 $0
Q1 2022 May 11, 2022	BUY	$31.97 - $41.06 $159 - $205	5 Added 19.23%	31 $1,000
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $127 - $163	-4 Reduced 13.33%	26 $1,000
Q3 2021 Nov 10, 2021	SELL	$38.47 - $46.42 $846 - $1,021	-22 Reduced 42.31%	30 $1,000
Q2 2021 Aug 10, 2021	BUY	$38.84 - $51.31 $388 - $513	10 Added 23.81%	52 $2,000
Q1 2021 May 06, 2021	SELL	$39.51 - $51.45 $987 - $1,286	-25 Reduced 37.31%	42 $2,000
Q4 2020 Feb 03, 2021	SELL	$25.81 - $43.62 $51 - $87	-2 Reduced 2.9%	67 $3,000
Q3 2020 Oct 30, 2020	BUY	$25.74 - $29.63 $617 - $711	24 Added 53.33%	69 $2,000
Q2 2020 Aug 14, 2020	SELL	$16.25 - $26.81 $211 - $348	-13 Reduced 22.41%	45 $1,000
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $881 - $1,026	58 New	58 $1,000

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$930 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$681 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$350 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$215 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$180 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account